Amylyx Pharmaceuticals, Inc. AMLX 深 沪
等待开盘 10-24 09:30:00 美东时间
14.31
-0.510
-3.44%
华盛通- 最 高15.07
- 今 开14.82
- 成交量 209.43万股
- 最 低 13.88
- 昨 收 14.82
- 总市值 15.31亿
- 52周最高 16.96
- 市盈率 静 --
- 换手率 1.96%
- 52周最低 2.60
- 委 比 43.11%
- 总股本 1.07亿
- 历史最高 41.9297
- 量 比 1.13
- 振 幅 8.03%
- 历史最低 1.575
- 每 手 1
- 风险率 3.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在最高涨幅37.45%，甲骨文获多家机构上调目标价；瑞穗上调美光科技目标价升至240美元
今日重点评级关注：韦德布什：维持Artiva Biotherapeutics"跑赢大市"评级，目标价从18美元升至23美元；巴克莱：维持Cellectis"超配"评级，目标价从4美元升至8美元
10-20 10:03
美股大行评级 | Needham上调台积电目标价升至360美元！美国银行、摩根士丹利分别获多家机构上调目标价
今日重点评级关注：Rosenblatt：维持HIVE Digital Technologies"买入"评级，目标价从5美元升至10美元；摩根大通：维持Array Technologies"超配"评级，目标价从13美元升至15美元
10-17 09:58
Baird Maintains Outperform on Amylyx Pharmaceuticals, Raises Price Target to $19
Baird analyst Joel Beatty maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Outperform and raises the price target from $10 to $19.
10-16 19:30
美股大行评级 | 潜在涨幅1176.6%！Ascendiant Capital上调Society Pass目标价至18美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从15美元升至18美元；Ascendiant Capital：维持Surgepays"买入"评级，目标价从9美元升至9.5美元
10-06 08:35
B of A Securities Maintains Buy on Amylyx Pharmaceuticals, Raises Price Target to $16
B of A Securities analyst Geoff Meacham maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Buy and raises the price target from $14 to $16.
10-03 21:06
美股大行评级 | Arete Research上调百度"买入"评级，目标价143美元；瑞银上调蔚来"买入"评级，目标价升至8.5美元
今日重点评级关注：HC Wainwright & Co.：维持Orion Energy Sys"买入"评级，目标价从2美元升至20美元；高盛：维持Amylyx Pharmaceuticals"买入"评级，目标价从10美元升至20美元
09-17 10:15
美股大行评级 | 潜在涨幅432.99%！维持"投机性买入"评级，Unicycive Therapeutics获机构升目标价至21美元
今日重点评级关注：Benchmark：维持Unicycive Therapeutics"投机性买入"评级，目标价从3美元升至21美元；Guggenheim：维持Amylyx Pharmaceuticals"买入"评级，目标价从17美元升至25美元
09-16 09:48
Amylyx股价上涨10.9%，此前完成1.75亿美元融资
美股周三早盘，制药商Amylyx Pharmaceuticals（AMLX）股价上涨10.9%，此前该公司宣布以每股10美元的价格完成1.75亿美元的公开发...
09-10 22:51
Amylyx Pharmaceuticals prices $175M public offering
Amylyx Pharmaceuticals (NASDAQ:AMLX) priced an underwritten public offering of 17.5M shares at a public offering price of $10.00 per share. All of the shares of common stock are being offered by Amy...
09-10 13:38
Amylyx Pharmaceuticals Announces An Underwritten Public Offering Of Its Common Stock; Financial Terms Not Disclosed
Amylyx Pharmaceuticals (NASDAQ:AMLX) Has Initiated An Underwritten Public Offering Of Its Common Stock, With All Shares Being Offered By The Company. The Underwriters Have A 30-day Option To Purchase Up To 15% Additional
09-10 04:03
